Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse eventsWeihong Zhang, Xiubao Ren, Xinwei Zhang et al.|Cancer Biology and Medicine|2021Cited by 9
Figure S1, Figure S2, Figure S3, Figure S4, and Figure S5 from Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien‐Hsing Chang, David M. Goldenberg, Yang Wang et al.|Unknown|2023Cited by 0
Figure S10 from Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien‐Hsing Chang, David M. Goldenberg, Yang Wang et al.|Unknown|2023Cited by 0
Figure S1, Figure S2, Figure S3, Figure S4, and Figure S5 from Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien‐Hsing Chang, David M. Goldenberg, Yang Wang et al.|Unknown|2023Cited by 0
Figure S10 from Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T CellsChien‐Hsing Chang, David M. Goldenberg, Yang Wang et al.|Unknown|2023Cited by 0